Wesfarmers (ASX:WES) is back in focus as traders watch key inflation data that could influence interest rate expectations and consumer spending, two forces closely tied to its core Bunnings and Kmart businesses.
See our latest analysis for Wesfarmers.
At a share price of A$80.96, Wesfarmers has seen some pressure recently, with a 90 day share price return of 9.07% and a slightly negative year to date move. Its 1 year total shareholder return of 15.9% and 5 year total shareholder return of 97.02% point to momentum that has been stronger over the longer term, while investors now weigh higher inflation risks against the company’s past investments in technology, AI and growth areas such as healthcare and lithium.
If inflation and rate expectations have you reassessing retail exposure, it can help to widen the lens and look at fast growing stocks with high insider ownership as potential alternatives worth investigating next.
With Wesfarmers trading around A$80.96, close to its A$80.82 analyst price target and with an intrinsic value estimate sitting slightly below the market, the key question is whether there is still a buying opportunity here or if future growth is already priced in.
With Wesfarmers last closing at A$80.96 against a narrative fair value of about A$80.82, the story hinges on steady but not explosive growth and what investors are prepared to pay for it.
Analysts expect earnings to reach A$3.5 billion (and earnings per share of A$3.05) by about September 2028, up from A$2.9 billion today. The analysts are largely in agreement about this estimate.
Curious how mid single digit growth, firm margins and a premium future P/E are all stitched together into that A$80 plus fair value? The narrative leans on detailed revenue forecasts, a tight earnings range and a specific discount rate to justify today’s valuation. Want to see exactly how those moving parts line up, and what has to go right for the numbers to hold?
Result: Fair Value of A$80.82 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on cost inflation staying manageable and new ventures like healthcare and lithium scaling as planned, with any stumble quickly challenging today’s A$80-plus story.
Find out about the key risks to this Wesfarmers narrative.
If you see the story differently or prefer to test the numbers yourself, you can create your own version in a few minutes by using Do it your way.
A great starting point for your Wesfarmers research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
If Wesfarmers is on your radar, do not stop there. Broaden your watchlist with focused stock ideas that match how you like to invest and manage risk.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com